|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 2159230 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09013122.8 |
| Date of filing the European patent application | 2001-08-07 | |
| (97) | Date of publication of the European application | 2010-03-03 |
| (45) | Date of publication and mention of the grant of the patent | 2014-10-29 |
| (46) | Date of publication of the claims translation | 2015-01-26 |
| (30) | Number | Date | Country code |
| 223360 P | 2000-08-07 | US | |
| 236826 P | 2000-09-29 | US | |
| 920137 | 2001-08-01 | US |
| (72) |
Giles-Komar, Jill, US
Knight, David, M., US
Heavner, George, US
Scallon, Bernard, US
Shealy, David, US
|
| (73) |
Janssen Biotech, Inc.,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-TNF antikūnai, kompozicijos, būdai ir panaudojimai |
| Anti-TNF antibodies, compositions, methods and uses |
| Payment date | Validity (years) | Amount | |
| 2020-07-24 | 347.00 EUR |